SCHEDULE: AIGH Capital Discloses Coya Therapeutics Stake

AIGH Capital Management LLC and Orin Hirschman have filed an amended Schedule 13G, disclosing beneficial ownership in Coya Therapeutics, Inc. common stock.

Summary

• Orin Hirschman beneficially owns 1,108,171 shares of Coya Therapeutics, Inc. common stock, representing 5.3% of the class.
• AIGH Capital Management LLC beneficially owns 975,404 shares of Coya Therapeutics, Inc. common stock, representing 4.7% of the class.
• The filing is an Amendment No. 3 to a Schedule 13G, jointly filed by AIGH Capital Management, LLC, AIGH Investment Partners, L.L.C., and Mr. Orin Hirschman.
• Mr. Hirschman serves as the Managing Member of AIGH Capital Management, LLC and president of AIGH LLC, with his ownership encompassing shares held indirectly through AIGH CM, directly by AIGH LLC, and directly by himself and his family.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership, providing factual information without indicating positive or negative sentiment regarding the issuer's performance or prospects.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• Securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders are informed of significant institutional and individual ownership stakes in Coya Therapeutics, Inc.

Key Dates

Keywords

Coya Therapeutics, AIGH Capital Management, Orin Hirschman, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor